Published on 11/03/2024
A highlight of the life sciences calendar, the awards dinner was back at the fabulous Concorde Conference Centre on 7
th March, with
339 attendees gathering for an evening of celebration and achievement.
The award winners
The judges were blown away by the (record) number and quality of the applications this year, and with THREE new categories for 2023, the awards have gone further in capturing the achievements of the sector than ever before.
Competition was fierce and we would like to take this opportunity to congratulate all the shortlisted companies. So without further ado, we are excited to announce the winners of each category as follows:
Demonstrating sustainability plus growth potential, the
Start-Up Award recipient,
NunaBio is a specialist DNA development company which has built a solid reputation for R&D flexibility and innovative approaches to complex and challenging projects, with a mission to unlock the full potential of genetic innovation.
The
Project of the Year Award, recognising those that have taken a major step forward in the area of research and demonstrated an innovative and novel approach, went to
Agile Life Sciences for MenoGuide. A diagnostic test, it measures the vaginal microbiome and accurately assesses the stage of menopause and monitors the impact of treatment for menopause.
Identifying high quality innovative products which have impacted significantly upon a problem within the life science industry or healthcare sector, the
Product of the Year Award winner was
MYoroface with their IQoro Neuromuscular Training Device, which strengthens and restores nerve pathway control and muscle strength throughout the swallowing chain.
The
Technical Service Award recipient,
Biofortuna, developed lyophilised bead IVD design (LyoBeads) and high throughput manufacture for POC devices and services in challenging environments due to their stability at room temperature, completing the development and validation of systems in 2023 to manufacture over one million LyoBeads per week.
New for 2023 and recognising the provision of innovative business support products and services, the
Business Support Award went to
Pharmaron, which doubled revenues and secured £151 million investment in capital and people from the UK Life Sciences Innovative Manufacturing Fund and Pharmaron Corporate to increase production capacity four-fold for gene therapies and vaccines, and create 174 jobs.
Celebrating an exceptional individual within the first five years of their life science career and having demonstrated significant contribution to their current role, the
Rising Star Award recipient,
Faith Howard of the
University of Sheffield and CEO and co-founder of
NANOncolytics. is no stranger to accolades, having already won the BACR Roger Griffin Prize for Cancer Drug Discovery, Best Company Pitch at the University of Edinburgh’s Venture Builder Incubator, and Cancer Research UK’s Top Innovations to Watch.
The next new award category was the
Social Impact Award, which recognises activities aimed at creating significant, positive societal changes by addressing a pressing and defined challenge. The winner,
The Christie NHS Foundation Trust, demonstrated this with a positive impact on the environment, EDI and sustainability achieved by improving sustainability of early phase clinical trials in the UK and in parallel supporting medical treatment across sub-Saharan Africa through re-distribution of consumables.
The recipient of the
Partnership & Collaboration Award, the
University of Manchester, was able to demonstrate an impressive collaboration with their more than 15-year skin health and ageing research partnership with
Boots, which has enabled new discoveries in skin biology to be incorporated into novel commercial products via a robust, clinical screening programme. Not only that, it has also brought several million pounds of investment into North-West bioscience, producing 100+ scientific publications, 10 patents and new employment opportunities.
Rounding off the new categories for 2023 was the
Internationalisation Award, for organisations trading their products, services, and expertise overseas, which went to
Cresset Biomolecular Discovery. Their patented CADD Software, collaborative Torx® DMTA design-make-test-analyse platform, and expert Discovery CRO scientists enables chemists to enhance efficiency and win the race to success in the global pharmaceuticals, agrochemicals, and flavours and fragrances industries.
The
Business Growth Award winner,
Gentronix, demonstrated sustained double digit percentage growth in 2021 and 2022, then further increased revenue by over 100% in 2023, with staff numbers also increasing by 43% in the last two years.
Demonstrating a significant capital raise of £500 million, the
Investment Deal of the Year Award recipient,
Bruntwood SciTech, partnered with the UK’s largest local authority pension fund,
Greater Manchester Pension Fund, to support the growth of the life science and tech sector. The deal was one of the most significant transactions in UK real estate in 2023.
The
Outstanding Contribution Award recognises an exceptional individual who has made a significant contribution to the sector throughout their career. This year’s recipient was
Liz Ashall-Payne, an accomplished healthcare leader and the Founding CEO of
ORCHA, a global leader in digital health accreditation and distribution services. Liz is also an
NHS England NIA alumni fellow, demonstrating her commitment to advancing innovation in healthcare. She actively contributes to the development of future healthcare leaders as a coach for the NHS England
Clinical Entrepreneur Programme and serves as the Vice Chair on the
Tech UK Health and Social Care Council, where she helps shape policies and initiatives in the intersection of technology and healthcare.
The final accolade of the night, the
Company of the Year Award, represents a leading, globally formidable company which has demonstrated significant progress year on year whilst also demonstrating notable progress during the past 12 months. This honour went to
Sterling Pharma Solutions, which secured further investors and investment and acquired new capabilities in 2023, and with growth in the UK and internationally, now boasts three sites in the UK, two in the US and one in Ireland, and is well-positioned to access key markets.
Commenting on an inspirational evening of celebration, Dr Geoff Davison, CEO of Bionow, said: “
We were excited to welcome everyone back to the Concorde Conference Centre this year for a bumper crop of awards and shortlisted nominees, with three new categories commemorating achievements in business support, internationalisation and social impact. We had a great turnout this year with lots of buzz around the event, and I would like to congratulate all the nominees for making it so tough to pick a winner! This truly reflects the excellent work going on in the life sciences industry currently. ”
The 2023 Bionow Awards is supported by Appleyard Lees and Bruntwood SciTech.
The full list of winners are:
Start-Up Award sponsored by RSM UK
NunaBio
Project of the Year Award sponsored by Waters Corporation
Agile Life Sciences: MenoGuide
Product of the Year Award sponsored by Health Innovation North West Coast | Health Innovation Yorkshire & Humber | Health Innovation Manchester
MYoroface: IQoro Neuromuscular Training Device
Technical Service Award sponsored by QIAGEN
Biofortuna: Lyophilised bead IVD design and high throughput manufacture
Business Support Award sponsored by Entrust Resource Solutions
Pharmaron: Gene Therapy Contract Development & Manufacturing Organisation
Rising Star Award sponsored by CSL Seqirus
Faith Howard,
University of Sheffield and
NANOncolytics
Social Impact Award sponsored by Square One Law
The Christie NHS Foundation Trust
Partnership & Collaboration Award sponsored by Mills & Reeve
University of Manchester: Skin health and ageing research with impact
Internationalisation Award sponsored by DLA Piper
Cresset Biomolecular Discovery
Business Growth Award sponsored by SRG
Gentronix
Investment Deal of the Year Award sponsored by Bouygues Energies and Services
Bruntwood SciTech: £500m Investment to grow the UK’s life science, tech and innovation economy
Outstanding Contribution Award sponsored by Sci-Tech Daresbury | Science and Technology Facilities Council
Liz Ashall-Payne, Founding CEO of
ORCHA
Company of the Year Award sponsored by AstraZeneca
Sterling Pharma Solutions